14-day Premium Trial Subscription Try For FreeTry Free
NYSE:MSTX
Delisted

Mast Therapeutics, Inc Fund Predictions

$0.130
+0 (+0%)
At Close: Jan 16, 2018
Currently predicting for Mon, 6 May 2024

MSTX Predictions History

7 years ago
Abdu predicted that MSTX for 2016-12-16 is going $0.100 (0.00%)

7 years ago
Abdu predicted that MSTX for 2016-12-14 is going $0.0900 (-10.00%)

7 years ago
Abdu predicted that MSTX for 2016-12-13 is going $0.100 (-9.09%)

7 years ago
Abdu predicted that MSTX for 2016-12-12 is going $0.0900 (-25.00%)

7 years ago
JS predicted that MSTX for 2016-12-12 is going $0.128 (6.67%)

7 years ago
Jordan.Barnes.1814 predicted that MSTX for 2016-12-12 is going $0.140 (16.67%)

Rank:

7 years ago
Mitch.Mullen.1722 predicted that MSTX for 2016-12-12 is going $0.0900 (-25.00%)

Rank:

7 years ago
Jeff.Breig.1806 predicted that MSTX for 2016-12-12 is going $0.110 (-8.33%)

Rank:

7 years ago
JS predicted that MSTX for 2016-11-29 is going $0.117 (30.00%)

7 years ago
Abdu predicted that MSTX for 2016-11-29 is going $0.0950 (-5.00%)

Click to get the best stock tips daily for free!

About Mast Therapeutics, Inc

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of hear... MSTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT